Uses of Bostanex

Bostanex drugs are manufactured and registered by Boston Vietnam Pharmaceutical Joint Stock Company. The drug belongs to the antiallergic group and is used in cases of hypersensitivity. Using Bostanex medicine exactly as prescribed by your doctor will help you ensure safety for your health and maximize the effectiveness of your treatment.

Bostanex medicine contains the main active ingredient is Desloratadine 0.5mg, is prepared in the form of syrup, packed in a box of 1 dark glass bottle with a capacity of 120ml, 100ml, 60ml and 30ml.

Bostanex medicine is indicated for use in the following cases:
Seasonal allergic rhinitis: In patients > 2 years old, Bostanex medicine rapidly relieves symptoms such as runny nose, sneezing, stuffy and itchy nose, watery eyes, cough, itchy throat ; Perennial allergic rhinitis: Bostanex is indicated for use in patients from 6 months of age, helping to quickly relieve symptoms of perennial allergic rhinitis; Chronic idiopathic urticaria: The indicated subjects are patients > 6 months old, the drug helps to quickly relieve the symptoms of itching, the size and number of the rash. Contraindications of the drug Bostanex:
Bostanex drug is contraindicated for use in patients with hypersensitivity to any component of the drug, including active ingredients and excipients in the solution; The patient has a history of allergy to Loratadine.

How to use:
Bostanex is prepared in the form of a solution, before use, it is necessary to shake the bottle well to mix the active ingredients and excipients in the drug. The drug is taken orally and can be taken before, during or after a meal.
Dosage of Bostanex is divided by age:
Children from 6 months to 11 months: 2ml (1mg), 1 time a day; Children from 1 to 5 years old: 2.5ml equivalent to half a teaspoon (1.25mg), once a day; Children from 6 to 11 years old: 5ml equivalent to 1 tea spoon (2.5mg), 1 time a day; Children > 12 years old and adults: Use 10ml equivalent to 2 teaspoons, once a day or use Bostanex drug preparation in the form of film-coated tablets. For each type of allergic rhinitis, there will be a different treatment regimen. With the intermittent form (symptoms appear for less than 4 days in 1 week or less than 4 weeks) treatment is based on assessment of the patient's history, treatment only when symptoms are present, stop treatment when symptoms disappear. With the prolonged form (symptoms appear on more than 4 days in 1 week or more than 4 weeks), treatment should be continued while the patient is exposed to the allergen.
Treatment when overdose:
When using Bostanex drug overdose, it is recommended that patients report to their doctor for advice or reasonable treatment for each degree of overdose.

When co-administering Bostanex with Cytochrome P450 3A4 inhibitors (Erythromycin, Ketoconazole, Azithromycin), an increase in plasma concentrations of 3-hydroxydesloratadine and desloratadine was observed, but not clinically apparent. When Bostanex and Fluoxetine were combined, the results showed an increase in plasma concentrations of 3-hydroxydesloratadine and desloratadine, similar to when Bostanex and Cimetidine were co-administered.

On the subject is young children aged 6 - 23 months, the side effects encountered such as fever, diarrhea, insomnia after using Bostanex. In adolescents and adults, when using the drug, the following undesirable effects will rarely occur: Occurrence of hallucinations; Nervous system disorders: Drowsiness, dizziness, insomnia, seizures, excessive neuromotor activity; Cardiovascular disorders: Tachycardia and palpitations; Digestive disorders: Nausea, dyspepsia, vomiting, abdominal pain, diarrhea; Hepatobiliary disorders: hepatitis, elevated liver enzymes, increased bilirubin; Occurrence of myalgia on the musculoskeletal system and connective tissue disorders; Systemic: Hypersensitivity reactions such as angioedema, allergy, rash, pruritus, dyspnea, urticaria. It is recommended that patients when using Bostanex medicine experience any unwanted effects to inform their doctor or medical staff.

When using Bostanex in children < 2 years old, it is necessary to clarify the following issues: Children do not have upper respiratory tract infections, no structural abnormalities, review the patient's history, evaluate test results and check for skin reactions. Bostanex should be used with caution in patients with severe renal impairment, family history or history of seizures, especially in children. Sorbitol is one of the excipients in Bostanex, so patients with fructose intolerance, sucrase - isomaltase deficiency or glucose - galactose malabsorption should not take Bostanex. In the drug product Bostanex contains 0.824mg Sodium; 667mg of white sugar, so people with diabetes or on a sodium diet need to be careful. For pregnant women: Use as directed by your doctor and only when the benefits outweigh the risks. For women who are breastfeeding: It is necessary to stop breastfeeding during the use of Bostanex. When patients drive or operate machinery, the use of Bostanex should be avoided. The article has provided information about the uses, dosage and precautions when using Bostanex. To ensure the safety of your health and maximize the effectiveness of treatment, you need to take the medicine exactly as directed by your doctor.